# EDGAR Filing Document

**Accession Number:** 0001421744
**File Stem:** 0001104659-26-012534
**Filing Date:** 2026-2
**Character Count:** 3346
**Document Hash:** a6a6b9f2c8e44223f88aaf62b8316cc4
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-26-012534.hdr.sgml**: 20260210

**ACCESSION NUMBER**: 0001104659-26-012534

**CONFORMED SUBMISSION TYPE**: C-AR

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20221231

**FILED AS OF DATE**: 20260210

**DATE AS OF CHANGE**: 20260210

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Cytonics Corp
- **CENTRAL INDEX KEY:** 0001421744
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 208883869
- **STATE OF INCORPORATION:** FL

**FILING VALUES:**
- **FORM TYPE:** C-AR
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 020-25262
- **FILM NUMBER:** 26615119

**BUSINESS ADDRESS:**
- **STREET 1:** 658 W INDIANTOWN RD
- **STREET 2:** SUITE 214
- **CITY:** JUPITER
- **STATE:** FL
- **ZIP:** 33458-7535
- **BUSINESS PHONE:** (561) 575-4451

**MAIL ADDRESS:**
- **STREET 1:** 658 WEST INDIANTOWN ROAD
- **STREET 2:** SUITE 214
- **CITY:** JUPITER
- **STATE:** FL

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CYTONICS CORP
- **DATE OF NAME CHANGE:** 20071219

### Attached PDF Documents

**Attachment 1:** `tm265088d1_car.pdf`

_No text found in this document._

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM C

### UNDER THE SECURITIES ACT OF 1933

### Issuer Information

**Name of Issuer:** Cytonics Corp

**Legal Status:** Corporation

**Jurisdiction of Incorporation/Organization:** FL

**Date of Organization:** 07-19-2006

**Physical Address:** 658 WEST INDIANTOWN ROAD, JUPITER, FL, 33458

**Issuer Website:** www.cytonics.com

**Is there a Co-Issuer?:** No

### Offering Information

**Oversubscription Accepted:** No

### Annual Report Disclosure Requirements

**Current Number of Employees:** 1.00

**Total Assets (Most Recent Fiscal Year):** $1,437,976.00

**Total Assets (Prior Fiscal Year):** $1,756,758.00

**Cash & Cash Equivalents (Most Recent Fiscal Year):** $1,166,390.00

**Cash & Cash Equivalents (Prior Fiscal Year):** $967,757.00

**Accounts Receivable (Most Recent Fiscal Year):** $100,000.00

**Accounts Receivable (Prior Fiscal Year):** $123,333.00

**Short-Term Debt (Most Recent Fiscal Year):** $304,246.00

**Short-Term Debt (Prior Fiscal Year):** $554,929.00

**Long-Term Debt (Most Recent Fiscal Year):** $0.00

**Long-Term Debt (Prior Fiscal Year):** $0.00

**Revenues/Sales (Most Recent Fiscal Year):** $405,000.00

**Revenues/Sales (Prior Fiscal Year):** $307,500.00

**Cost of Goods Sold (Most Recent Fiscal Year):** $0.00

**Cost of Goods Sold (Prior Fiscal Year):** $0.00

**Taxes Paid (Most Recent Fiscal Year):** $0.00

**Taxes Paid (Prior Fiscal Year):** $0.00

**Net Income (Most Recent Fiscal Year):** $2,844,674.00

**Net Income (Prior Fiscal Year):** $2,544,189.00

### Signatures

**Issuer:** Cytonics Corporation

**Signature:** /s/ Anjun (Joey) Bose,

**Title:** CEO

---

**Signature:** /s/ Anjun (Joey) Bose

**Title:** Director, CEO, Principal Executive Officer, Principal Accounting and Financial Officer

**Date:** 02-10-2026

---

**Signature:** /s/ Gaetano Scuderi

**Title:** Director

**Date:** 02-10-2026

---

**Signature:** /s/ Gordon Ramseier

**Title:** Director

**Date:** 02-10-2026

---

**Signature:** /s/ Tracy Goeken

**Title:** Director

**Date:** 02-10-2026